The Price of Global : Drug Pricing Strategies to Balance Patient Access and the Funding of Innovation

undefined

Public debate continues to intensify in the US and many other countries due to the rising cost of new biotechnology drug s and concern over patient ability to (co-)pay and adhere to these expensive s. Demand for new effective medical and drug s meanwhile continues to rise as uny lifestyles further cause increases in es and cardiovascular disease, thus further adding to the problem.Global drug pricing is one of the most hotly debated yet least understood aspects of the ceutical industry. How should drug prices be set and what does it mean for patients? Why do governments increasingly get involved, and what is its impact on the global competitive environment? How can a life-saving industry have a poorer image than and industries that produce products that kill? Ed Schoonveld explains how ceutical prices are determined in a complex global player environment and what factors influence the process. His ins will help a wide range of audiences - from care industry professionals to policy makers and the broader public - to gain a better understanding of this highly complex and emotionally charged field.The Price of Global is the first book of its kind: an in-depth but straightforward exploration of the ceutical pricing strategy process, its underlying market access, general business and ethical considerations, and its implications for payers, physicians and patients. It is a much-needed and invaluable resource for anybody interested or involved in, or affected by the development, funding and use of prescription drugs. In particular, it is of critical importance to ceutical company executives and other leaders and professionals in commercialization and drug development, including marketing, business development, market access and pricing, clinical development, drug discovery, regulatory affairs, outcomes, market research and public affairs.The second edition contains a large a of new content, including four new chapters, many updates, new examples and all new illustrations. Furthermore, the country system descriptions have been updated to reflect Obamacare, AMNOG in Germany and many other changes.